Notification for retail price fixation of 39 new drugs

REGD. No. D. L.-33004/99 The Gazette of India CG-DL-E-09072026-274327 EXTRAORDINARY PART II-Section 3-Sub-section (ii) PUBLISHED BY AUTHORITY No. 3547] NEW DELHI, WEDNESDAY, JULY 8, 2026/ASHADHA 17, 1948 5146 GI/2026 MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals) (NATIONAL PHARMACEUTICAL PRICING AUTHORITYNOTIFICATION) ORDER New Delhi, the 8th July, 2026 S.O. 3709(E). — In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013, S.O. 5249(E) dated 11th November, 2022 and S.O. 3516(E) dated 30th June, 2026 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof; TABLE +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | SI. | Name of the Formulation / | Strength | Unit | Manufacturer & Marketing Company | Retail Price | | No. | Brand Name | | | | (Rs.) | +=====+=====================================+=============================================+============+==========================================+================+ | (1) | (2) | (3) | (4) | (5) | (6) | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 1 | Amlodipine, | Each Film Coated Bilayered Tablet Contains: | 1 Tablet | M/s Akums Drugs & | 12.03 | | | Telmisartan and | Amlodipine Besilate IP Eq. to Amlodipine 5 | | Pharmaceuticals Ltd./ | | | | Metoprolol | mg | | M/s Ipca Laboratories Ltd. | | | | Succinate | Telmisartan IP 40 mg | | | | | | (Extended Release) | Metoprolol Succinate IP 23.75 mg | | | | | | Tablets | Eq. to Metoprolol Tartrate 25 mg (As | | | | | | | Extended Release Form) | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 2 | Amoxicillin and | Each Uncoated Dispersible Tablet contains: | 1 Tablet | M/s Malik Lifesciences Pvt. | 27.31 | | | Potassium | Amoxicillin Trihydrate IP Eq. to Amoxicillin| | Ltd./ | | | | Clavulanate | 400 mg | | M/s Mankind Pharma Ltd. | | | | Dispersible Tablets | Potassium Clavulanate Diluted IP Eq. to | | | | | | | Clavulanic Acid 57 mg | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 3 | Amoxycillin and | Each film coated tablet contains: | 1 Tablet | M/s Alkem Health Science | 19.53 | | | Potassium | Amoxicillin Trihydrate IP equivalent to | | (A unit of Alkem | | | | Clavulanate Tablets | Amoxicillin 250 mg | | Laboratories Ltd.)/ | | | | | Potassium Clavulanate Diluted IP equivalent | | M/s Alkem Wellness Ltd. | | | | | to Clavulanic Acid 125 mg | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 4 | Aspirin and Gastro- | Each hard gelatin capsule contains: | 1 Capsule | M/s Windlas Biotech Ltd./ | 3.67 | | | Resistant Atorvastatin | Aspirin IP 75 mg | | M/s Aristo Pharmaceuticals | | | | Capsules | (as gastro-resistant white colored pellets) | | Pvt. Ltd. | | | | | Atorvastatin Calcium IP eq. to Atorvastatin | | | | | | | 20 mg | | | | | | | (as green colored spherical pellets) | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 5 | Aspirin, | Each hard gelatin capsule contains: | 1 Capsule | M/s Safetab Life Science/ | 8.86 | | | Atorvastatin and | Aspirin IP 75mg (As Gastro-resistant tablet)| | M/s Alkem Wellness Ltd. | | | | Clopidogrel Capsules | Atorvastatin Calcium IP equivalent to | | | | | | | Atorvastatin 20mg (As film coated tablet) | | | | | | | Clopidogrel Bisulphate IP equivalent to | | | | | | | Clopidogrel 75mg | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 6 | Atorvastatin and | Each Film Coated Tablet Contains: | 1 Tablet | M/s Mascot Health Series | 31.73 | | | Ezetimibe Tablets | Atorvastatin Calcium IP Eq. to Atorvastatin | | Pvt. Ltd./ | | | | | 20 mg | | M/s Primus Remedies Pvt. | | | | | Ezetimibe IP 10 mg | | Ltd. | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 7 | Atorvastatin and | Each Film Coated Tablet Contains: | 1 Tablet | M/s Mascot Health Series | 21.36 | | | Ezetimibe tablets | Atorvastatin Calcium IP Eq. to Atorvastatin | | Pvt. Ltd./ | | | | | 10 mg | | M/s Primus Remedies Pvt. | | | | | Ezetimibe IP 10 mg | | Ltd. | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 8 | Atorvastatin and | Each uncoated bilayer tablet contains: | 1 Tablet | (i) M/s Sun Pharma | 14.87 | | | Clopidogrel Tablets | Atorvastatin Calcium IP equivalent to | | Laboratories Limited/ | | | | | Atorvastatin 10 mg | | M/s Sun Pharmaceutical | | | | | Clopidogrel Bisulphate IP equivalent to | | Industries Ltd. and | | | | | Clopidogrel 75 mg | | (ii) M/s Sun Pharma | | | | | | | Laboratories Limited | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 9 | Atorvastatin and | Each uncoated bilayer tablet contains: | 1 Tablet | (i) M/s Sun Pharma | 15.01 | | | Clopidogrel Tablets | Atorvastatin Calcium IP equivalent to | | Laboratories Limited/ | | | | | Atorvastatin 20 mg | | M/s Sun Pharmaceutical | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 10 | Bisoprolol Fumarate | Each Film Coated Tablet Contains: | 1 Tablet | M/s Akums Drugs & | 12.71 | | | and Telmisartan Tablets | Bisoprolol Fumarate IP 5 mg | | Pharmaceuticals Ltd./ | | | | | Telmisartan IP 40 mg | | M/s Workcell Solutions Pvt. | | | | | | | Ltd. | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 11 | Bisoprolol Fumarate | Each Film Coated Tablet Contains: | 1 Tablet | M/s Akums Drugs & | 10.83 | | | and Telmisartan Tablets | Bisoprolol Fumarate IP 2.5 mg | | Pharmaceuticals Ltd./ | | | | | Telmisartan IP 40 mg | | M/s Workcell Solutions Pvt. | | | | | | | Ltd. | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 12 | Cetirizine Hydrochloride | Each ml contains: | 1 ML | M/s Indoco Remedies | 8.55 | | | Drops | Cetirizine Hydrochloride IP 10 mg | | Limited | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 13 | Clobazam Oral | Each ml contains: | 1 ML | M/s Pure and Cure | 2.80 | | | Suspension | Clobazam IP 2.5 mg | | Healthcare Pvt. Ltd. / | | | | | | | M/s Linux Laboratories | | | | | | | Private Limited | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 14 | Dapagliflozin and | Each film coated tablet contains: | 1 Tablet | M/s Exemed | 19.30 | | | Telmisartan Tablets | Dapagliflozin Propanediol USP eq. to | | Pharmaceuticals/ | | | | | Dapagliflozin 10 mg | | M/s Mankind Pharma Ltd. | | | | | Telmisartan IP 40 mg | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 15 | Empagliflozin, | Each Film Coated Bilayered Tablet Contains: | 1 Tablet | M/s Pure and Cure | 14.88 | | | Sitagliptin and | Empagliflozin 10 mg | | Healthcare Pvt. Ltd./ | | | | Metformin | Sitagliptin Phosphate Monohydrate IP | | M/s Medley Pharmaceuticals | | | | Hydrochloride (ER) | Eq. to Sitagliptin 100 mg | | Ltd. | | | | Tablets | Metformin Hydrochloride IP 1000 mg | | | | | | | (As Extended Release) | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 16 | Empagliflozin, | Each Film Coated Bilayered Tablet Contains: | 1 Tablet | M/s Pure and Cure | 17.17 | | | Sitagliptin and | Empagliflozin 25 mg | | Healthcare Pvt. Ltd./ | | | | Metformin | Sitagliptin Phosphate Monohydrate IP | | M/s Medley Pharmaceuticals | | | | Hydrochloride (ER) | Eq. to Sitagliptin 100 mg | | Ltd. | | | | Tablets | Metformin Hydrochloride IP 1000 mg | | | | | | | (As Extended Release) | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 17 | Nebivolol | Each uncoated tablet contains: | 1 Tablet | M/s Windlas Biotech Ltd./ | 13.72 | | | Hydrochloride and | Nebivolol Hydrochloride IP equivalent to | | M/s Alkem Wellness Ltd. | | | | Amlodipine Tablets | Nebivolol 5 mg | | | | | | | Amlodipine Besilate IP equivalent to | | | | | | | Amlodipine 5 mg | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 18 | Olmesartan | Each film coated tablet contains: | 1 Tablet | M/s Windlas Biotech Ltd./ | 14.80 | | | Medoxomil and | Olmesartan Medoxomil IP 20 mg | | M/s Alkem Wellness Ltd. | | | | Amlodipine Tablets | Amlodipine Besilate IP | | | | | | | eq. to Amlodipine 5 mg | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 19 | Phenylephrine HCI, | Composition: | 1 ML | M/s Appasamy Ocular | 8.35 | | | Chlorpheniramine | Phenylephrine HCI IP 0.12%w/v | | Devices Pvt. Ltd./ | | | | Maleate, Boric Acid | Chlorpheniramine Maleate IP 0.2% w/v | | M/s Mankind Pharma Ltd. | | | | and | Boric Acid IP 1.25%w/v | | | | | | Hydroxypropylmet | Hydroxypropylmethyl Cellulose IP 0.3%w/v | | | | | | hyl Cellulose Eye | Benzalkonium Chloride IP 0.01%w/v | | | | | | Drops | | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 20 | Polmacoxib and | Each uncoated tablet contains: | 1 Tablet | M/s Hetero Labs Ltd./ | 11.79 | | | Paracetamol tablets | Polmacoxib IH 2 mg | | M/s La Renon Healthcare | | | | | Paracetamol IP 325 mg | | Pvt. Ltd. | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 21 | Telmisartan and | Each uncoated bilayered tablet contains: | 1 Tablet | M/s Windlas Biotech Ltd./ | 13.03 | | | Chlorthalidone | Telmisartan IP 40 mg | | M/s Alkem Wellness Ltd. | | | | Tablets | Chlorthalidone IP 12.5 mg | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 22 | Telmisartan and | Each uncoated bilayered tablet contains: | 1 Tablet | M/s Windlas Biotech Ltd./ | 21.40 | | | Chlorthalidone | Telmisartan IP 80 mg | | M/s Alkem Wellness Ltd. | | | | Tablets | Chlorthalidone IP 12.5 mg | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 23 | Telmisartan and | Each uncoated bilayered tablet contains: | 1 Tablet | M/s Windlas Biotech Ltd./ | 11.80 | | | Chlorthalidone | Telmisartan IP 40 mg | | M/s Alkem Wellness Ltd. | | | | Tablets | Chlorthalidone IP 6.25 mg | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 24 | Telmisartan and | Each Film coated tablet contains: | 1 Tablet | (i) M/s Synokem | 13.24 | | | Cilnidipine Tablets | Telmisartan IP 40mg | | Pharmaceuticals Limited/ | | | | | Cilnidipine IP 10mg | | M/s FDC Limited' and | | | | | | | (ii) M/s Synokem | | | | | | | Pharmaceuticals Ltd./ | | | | | | | M/s Alkem Wellness Ltd. | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 25 | Telmisartan, | Each film coated tablet contains: | 1 Tablet | M/s Synokem | 16.17 | | | Cilnidipine and | Telmisartan IP 40 mg | | Pharmaceuticals Limited/ | | | | Chlorthalidone | Cilnidipine IP 10 mg | | M/s Alkem Wellness Ltd. | | | | Tablets | Chlorthalidone IP 6.25 mg | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 26 | Torsemide and | Each Uncoated Tablet Contains: | 1 Tablet | M/s Pure and Cure | 3.71 | | | Spironolactone | Torsemide IP 10 mg | | Healthcare Pvt. Ltd./ | | | | Tablets | Spironolactone IP 25 mg | | M/s RPG Life Sciences Ltd. | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 27 | Trypsin- | Each film coated tablet contains: | 1 Tablet | M/s Synokem | 13.02 | | | Chymotrypsin, | 50,000 Armour units of enzymatic activity | | Pharmaceuticals Limited/ | | | | Aceclofenac and | (Supplied by a purified concentrate which has| | M/s Medley Pharmaceuticals | | | | Paracetamol Tablets | specific Trypsin & Chymotrypsin activity in | | Limited | | | | | a ratio of approximately Six to One) (As | | | | | | | enteric coated granules) | | | | | | | Aceclofenac IP 100 mg | | | | | | | Paracetamol IP 325 mg | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 28 | Vitamin D3 Oral | Each 5 ml contains: | 1 ML | (i) M/s Tirupati Medicare | 15.88 | | | Solution | Cholecalciferol IP 60000 IU | | Ltd./ | | | | | (In Nano Droplet Form) | | M/s German Remedies | | | | | | | Pharmaceuticals Pvt. Ltd.; | | | | | | | (ii) M/s Windlas Biotech | | | | | | | Limited/ | | | | | | | M/s FDC Limited; and | | | | | | | (iii) M/s Tirupati Medicare | | | | | | | Ltd./ | | | | | | | M/s Aristo Laboratories Pvt. | | | | | | | Ltd | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 29 | Tenecteplase (TNK- | Each vial contains: | 1 Vial | M/s Boehringer Ingelheim | 60238.27 | | | TPA) Injection | Tenecteplase 50 mg (10000 units) | | India Pvt. Ltd. | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 30 | Netarsudil & | Each ml contains: | 1 ML | M/s Pure and Cure | 362.57 | | | Latanoprost | Netarsudil Mesylate | | Healthcare Pvt. Ltd./ | | | | Ophthalmic | Eq. to Netarsudil 0.2 mg | | M/s Sun Pharma Laboratories | | | | Solution | Latanoprost IP 0.05 mg | | Ltd. | | | | | Benzalkonium Chloride IP 0.2 mg | | | | | | | (As preservative) | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 31 | Imatinib Oral | Each ml contains: | 1 ML | M/s Beta Drugs Ltd. | 59.61 | | | Solution | Imatinib Mesylate IP Eq. to Imatinib 80 mg | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 32 | Amlodipine, | Each film coated tablet contains: Amlodipine| 1 Tablet | (i) M/s Ravenbhel Healthcare | 12.81 | | | Bisoprolol & | Besylate IP eq. to Amlodipine 5 mg | | Pvt. Ltd./ | | | | Telmisartan Tablets | Bisoprolol FumarateIP 2.5 mg Telmisartan IP | | M/s Glenmark | | | | | 40 mg | | Pharmaceuticals Ltd.; and | | | | | | | (ii) M/s Ravenbhel | | | | | | | Healthcare Pvt. Ltd./ | | | | | | | M/s Torrent Pharmaceuticals | | | | | | | Ltd. | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 33 | Amlodipine, | Each film coated tablet contains: Amlodipine| 1 Tablet | (i) M/s Ravenbhel Healthcare | 14.74 | | | Bisoprolol & | Besylate IP eq. to Amlodipine 5 mg | | Pvt. Ltd./ | | | | Telmisartan Tablets | Bisoprolol FumarateIP 5 mg | | M/s Glenmark | | | | | Telmisartan IP 40 mg | | Pharmaceuticals Ltd.; and | | | | | | | (ii) M/s Ravenbhel | | | | | | | Healthcare Pvt. Ltd./ | | | | | | | M/s Torrent Pharmaceuticals | | | | | | | Ltd. | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 34 | Nepafenac& | Composition: | 1 ML | M/s Akums Drugs & | 68.64 | | | Moxifloxacin | Nepafenac IP 0.1% w/v | | Pharmaceuticals Ltd./ | | | | Ophthalmic | Moxifloxacin Hydrochloride IP Eq. | | M/s Cipla Ltd. | | | | Solution | Moxifloxacin 0.5% w/v | | | | | | | Benzalkonium Chloride Solution IP 0.01% | | | | | | | w/v (As Preservative) | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 35 | Combikit of | Part A- | 1 Kit | M/s Emcure Pharmaceuticals | 330.40 | | | Darunavir, | Each film coated tablet contains: Darunavir | | Ltd. | | | | Ritonavir & | Ethanolate IP Eq. to Darunavir 800 mg | | | | | | Dolutegravir | Ritonavir IP 100 mg | | | | | | Tablets | Part B- | | | | | | | Each film coated tablet contains Dolutegravir | | | | | | | Sodium IP Eq. to Dolutegravir 50 mg | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 36 | Clopidogrel, | Each hard gelatin capsule contains: | 1 Capsule | M/s Safetab Life Science/ | 6.37 | | | Aspirin and | Atorvastatin Calcium IP eq. to Atorvastatin | | M/s Alkem Wellness Ltd. | | | | Atorvastatin | 10 mg (As film coated tablet) | | | | | | Capsules | Clopidogrel Bisuiphate IP eq. to Clopidogrel| | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 37 | Glimepiride, | Aspirin IP 75mg (As Gastro-resistant tablet)| 1 Tablet | M/s Windlas Biotech Ltd./ | 8.85 | | | Voglibose and | Each uncoated bilayered tablet contains: | | M/s Primus Remedies Pvt. | | | | Metformin | Glimepiride IP 0.5 mg | | Ltd. | | | | Hydrochloride (SR) | Voglibose IP 0.2 mg | | | | | | Tablets | Metformin Hydrochloride IP 500 mg | | | | | | | (as sustained release form) | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 38 | Sitagliptin, | Each film coated tablet contains: | 1 Tablet | M/s Synokem | 13.27 | | | Metformin | Sitagliptin Phosphate Monohydrate IP | | Pharmaceuticals Limited/ | | | | Hydrochloride and | eq. to Sitagliptin 50mg | | M/s Alkem Wellness Ltd. | | | | Glimepiride Tablets | Metformin Hydrochloride IP 1000mg | | | | | | | Glimepiride IP 2mg | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ | 39 | Sitagliptin, | Each film coated tablet contains: | 1 Tablet | M/s Synokem | 11.75 | | | Metformin | Sitagliptin Phosphate Monohydrate IP | | Pharmaceuticals Limited/ | | | | Hydrochloride and | eq. to Sitagliptin 50 mg | | M/s Alkem Wellness Ltd. | | | | Glimepiride Tablets | Metformin Hydrochloride IP 1000 mg | | | | | | | Glimepiride IP 1mg | | | | +-----+-------------------------------------+---------------------------------------------+------------+------------------------------------------+----------------+ Notes: (a) The manufacturer, as mentioned in column (5) of the table above, of formulations i.e., "new drug" under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price not exceeding the price as specified in column (6) of the table above. (b) Any other existing manufacturer launching the same new drug as specified in column (2), (3) and (4) of table above within twelve months of the date of publication of this notification in the Official Gazette is permitted to do so at a retail price not exceeding the price as specified in column (6) of the table above subject to filing of Form-IA on IPDMS 2.0 along with supporting documents within one month of launch. (c) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table. (d) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form-V from date of notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (e) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. [PN/280/148/2026/F / F. No. 8(148)/2026/D.P./NPPA-Div.-II] BHIVA RAM YADAV, Assistant Director Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054.